Patient-Centered Approaches To Drug Discovery: CEO Sarah Boyce's Vision For Avidity Biosciences

Recorded on 03/05/25

TD Cowen senior biotech analyst Ritu Baral speaks with Avidity Bioscience's President and CEO Sarah Boyce from TD Cowen's 45th Annual Health Care Conference. Boyce describes how her desire to meaningfully impact patient lives motivated her to become a biotech CEO, highlighting the vision, resilience, and adaptability needed to build a biotech company. One of 2017's "Fiercest Women in Life Sciences," Boyce shares her thoughts on the importance of a patient-driven mission, integrating patient advocacy and market access as key pillars in Avidity's strategic plan. Her insights are notable for anyone interested in Avidity Biosciences, the biotech industry, or patient-centered approaches to drug discovery.

https://go.td.com/PodcastDisclosure